会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Detection of disease related genes
    • 检测疾病相关基因
    • US06566070B2
    • 2003-05-20
    • US09943120
    • 2001-08-30
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • C12Q168
    • A61K41/0042A61K38/00C07C205/45C07C205/57C07D207/404C07D311/16C07D405/12C07D495/04C07H19/04C07H21/00C07K1/1077C07K1/13C12P21/00C12Q1/6883G01N33/58
    • The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other maninials, and kits which may be used for the detection of diseases and disorders.
    • 本发明涉及用于在细胞或无细胞翻译系统中翻译的新生蛋白的非放射性标记,检测,定量和分离的方法。 tRNA分子被非放射性标记物错氨基酰化,其可以是非天然氨基酸,氨基酸类似物或衍生物,或由蛋白质合成机理识别的物质。 标记可以包含可切割部分,可检测标记,报告基因特性,其中掺入蛋白质的标记可以与非组合标记物或促进从翻译系统的其他组分检测和分离新生蛋白质的偶联剂区别。 本发明还包括使用可以用于治疗人类和其他肌肉疾病和病症的药物组合物中的使用错氨基酰化tRNA制备的蛋白质,以及可用于检测疾病和病症的试剂盒。
    • 52. 发明授权
    • Methods for the detection and isolation of proteins
    • 检测和分离蛋白质的方法
    • US06210941B1
    • 2001-04-03
    • US09290325
    • 1999-04-12
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • C12N900
    • A61K41/0042A61K38/00C07C205/45C07C205/57C07D207/404C07D311/16C07D405/12C07D495/04C07H19/04C07H21/00C07K1/1077C07K1/13C12P21/00C12Q1/6883G01N33/58
    • The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other mammals, and kits which may be used for the detection of diseases and disorders.
    • 本发明涉及用于在细胞或无细胞翻译系统中翻译的新生蛋白的非放射性标记,检测,定量和分离的方法。 tRNA分子被非放射性标记物错氨基酰化,其可以是非天然氨基酸,氨基酸类似物或衍生物,或由蛋白质合成机理识别的物质。 标记可以包含可切割部分,可检测标记,报告基因特性,其中掺入蛋白质的标记可以与非组合标记物或促进从翻译系统的其他组分检测和分离新生蛋白质的偶联剂区别。 本发明还包括使用可用于治疗人类和其他哺乳动物疾病和病症的药物组合物中的使用错氨基酰化tRNA制备的蛋白质,以及可用于检测疾病和病症的试剂盒。